Forest Seeks FDA Nod for MDD Drug – Analyst Blog

By | September 28, 2012
0 Comment

Forest Laboratories, Inc. ( FRX ) continues to progress with its pipeline. The company and Pierre Fabre Laboratories recently submitted a new drug application for levomilnacipran

Read the article:
Forest Seeks FDA Nod for MDD Drug – Analyst Blog

Related posts:

  1. Earnings Scorecard: Forest Labs – Analyst Blog
  2. FDA Accepts Merck’s Sleep Drug NDA – Analyst Blog
  3. Bayer Seeks European Approval – Analyst Blog
  4. Forest Oil to Sell Non-Core Assets – Analyst Blog